Q-omics provides the consensus-scored TUBBP10 profile across patient tissues and cancer cell-line models. TUBBP10 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, TUBBP10 is differentially expressed in 5, with the highest sampling consensus in KIRC. Additionally, TUBBP10 RNA expression shows 9,512 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight BLCA, KIRC, and TGCT as cancer lineages where TUBBP10 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for TUBBP10 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes TUBBP10 survival associations across molecular data types. TUBBP10 RNA expression shows survival associations in the most cancer types (24). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible TUBBP10 RNA expression–survival associations across cancer types. High TUBBP10 expression shows unfavorable associations in BLCA, THCA, SARC and ACC, but favorable associations in UCS and BRCA. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for TUBBP10 RNA expression.
This table summarizes TUBBP10 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for TUBBP10. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. TUBBP10 shows higher tumor expression in KIRC, LUAD, UCEC, READ and LUSC. The KIRC box plot shows higher TUBBP10 RNA expression in tumor versus normal tissue (log2 FC = +0.067, t-test p < 0.001).
This table shows molecular features associated with TUBBP10 in patient tissues and cancer cell lines. In patient samples, TUBBP10 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
